Pfaff, N., S. Liebhaber, S. Mobus, A. Beh-Pajooh, J. Fiedler, A. Pfanne, A. Schambach, T. Thum, T. Cantz and T. Moritz: Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors. In: Stem Cell Res 20, 70-75 (2017).
url: https://www.ncbi.nlm.nih.gov/pubmed/28314201
Lachmann, N., J. Jagielska, D. Heckl, S. Brennig, N. Pfaff, T. Maetzig, U. Modlich, T. Cantz, B. Gentner, A. Schambach and T. Moritz: MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. In: Gene Ther 19, 9, 915-924 (2012).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21975463
Pfaff, N., N. Lachmann, S. Kohlscheen, M. Sgodda, M. J. Arauzo-Bravo, B. Greber, W. Kues, S. Glage, C. Baum, H. Niemann, A. Schambach, T. Cantz and T. Moritz: Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. In: Stem Cells Dev 21, 5, 689-701 (2012).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21732815
Pfaff, N., T. Moritz, T. Thum and T. Cantz: miRNAs involved in the generation, maintencance, and differentiation of pluripotent stem cells. In: J Mol Med 90, 7, 747-752 (2012).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.